Sherrif F. Ibrahim, MD, PhD

home / authors / sherrif-f-ibrahim-md-phd

Articles

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 30th 2022

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.

Patient Case: 49-Year-Old Caucasian Woman With Neglected Large BCC

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 30th 2022

Sherrif F. Ibrahim, MD, PhD, presents the case of a 49-year-old White woman with neglected large basal cell carcinoma.

Future of BCC

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 30th 2022

Expert dermatologists discuss future directions for the management of basal cell carcinoma.

Immune Checkpoint Inhibitors Utilized in BCC

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 23rd 2022

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, discuss the impact of immune checkpoint inhibitors used in BCC.

BCC Treatment Landscape

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 23rd 2022

Experts in dermatology discuss the treatment landscape for BCC.

Best Practices for Preventing Advanced BCC and the Importance of Multidisciplinary Teams

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 16th 2022

Drs Sherrif F. Ibrahim and Vishal Patel discuss the importance of a multidisciplinary team in the treatment of BCC as well as best practices for preventing advanced BCC.

Overview and Burden of BCC

Sherrif F. Ibrahim, MD, PhD;Vishal Patel, MD, FAAD, FACMS

September 16th 2022

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide an overview of BCC and discuss disease burden.